SMTL ID : 6rz8.1

Crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ONO-2080365

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x KNZ: (2~{S})-8-[[4-[4-[2,3-bis(fluoranyl)phenoxy]butoxy]-2-fluoranyl-phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-but yl)-2,3-dihydro-1,4-benzoxazine-2-carboxylic acid(Non-covalent)

KNZ.1: 26 residues within 4Å: Chain A: K.21, F.25, Y.82, S.99, Y.103, Y.107, Y.111, L.149, I.150, S.153, S.154, L.157, L.172, E.173, L.174, K.178, L.182, M.185, N.186, A.189, G.193, R.350, L.354, H.367, L.370, V.371 24 PLIP interactions: 24 interactions with chain A Hydrophobic interactions: A:Y.107, A:Y.107, A:Y.111, A:I.150, A:L.157, A:L.174, A:L.182, A:A.189, A:R.350, A:L.354, A:L.370, A:V.371 Hydrogen bonds: A:Y.82, A:Y.103, A:Y.103, A:Y.103 Water bridges: A:K.21, A:K.21, A:Y.82, A:L.172 Salt bridges: A:K.21, A:K.178, A:H.367 pi-Stacking: A:Y.103

10 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.2: 13 residues within 4Å: Chain A: S.67, L.70, S.73, T.74, F.77, F.90, A.94, I.97, S.101, V.104, N.105 Ligands: OLC.6, OLA.13 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:T.74, A:F.77, A:F.77, A:A.94, A:I.97, A:V.104 OLC.3: 7 residues within 4Å: Chain A: R.22, E.23, P.26, I.27, L.30, I.31 Ligands: OLC.11 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.27, A:L.30, A:L.30, A:I.31, A:I.31 Hydrogen bonds: A:R.22, A:E.23 OLC.4: 6 residues within 4Å: Chain A: T.348, V.352, C.362, K.363, L.366 Ligands: OLC.10 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:T.348, A:V.352, A:L.366 OLC.5: 5 residues within 4Å: Chain A: F.20, E.23, F.24, I.27 Ligands: OLA.14 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:I.27 OLC.6: 5 residues within 4Å: Chain A: I.66, L.69, L.70, S.73 Ligands: OLC.2 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.66, A:L.69, A:L.69, A:L.70 OLC.7: 4 residues within 4Å: Chain A: L.190, T.351, V.352, T.355 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.190, A:T.351, A:V.352, A:T.355 OLC.8: 1 residues within 4Å: Chain A: T.200 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:T.200 OLC.9: 9 residues within 4Å: Chain A: F.24, V.28, V.35, L.376, A.379, C.382, F.383, L.386 Ligands: OLC.11 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.24, A:V.28, A:L.376, A:A.379, A:F.383, A:F.383, A:L.386 OLC.10: 3 residues within 4Å: Chain A: F.340, L.344 Ligands: OLC.4 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:F.340, A:L.344 OLC.11: 11 residues within 4Å: Chain A: V.35, G.39, L.42, S.43, V.46, F.47, P.385, Y.388, Y.389 Ligands: OLC.3, OLC.9 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:V.35, A:L.42 Hydrogen bonds: A:Y.388

3 x OLA: OLEIC ACID(Non-covalent)

OLA.12: 3 residues within 4Å: Chain A: S.73, D.80, R.84 No protein-ligand interaction detected (PLIP) OLA.13: 2 residues within 4Å: Chain A: I.89 Ligands: OLC.2 No protein-ligand interaction detected (PLIP) OLA.14: 3 residues within 4Å: Chain A: F.20, K.368 Ligands: OLC.5 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:F.20 Salt bridges: A:K.368

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gusach, A. et al., Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. Nat Commun (2019)

Release Date

2019-12-11

Peptides

Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2

Related Entries With Identical Sequence